Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>DLBCL R/R*** > USA. A. Assess MRD Using ctDNA

---

USA. A. Assess MRD Using ctDNA's subsections
(*) USA Launch Date: 2022. 12.01
Company
RTM
RTM Web-Site
UpDate: 2023. 02.05
USA Patent Numbers:

USA. A. Assess MRD Using ctDNA's products
This section has no products